Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jan 3;3(1):e1917597.
doi: 10.1001/jamanetworkopen.2019.17597.

Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis

Alexandre R Marra  1   2   3 , Eli N Perencevich  1   3 , Richard E Nelson  4   5 , Matthew Samore  4   5 , Karim Khader  4   5 , Hsiu-Yin Chiang  6 , Margaret L Chorazy  1 , Loreen A Herwaldt  1 , Daniel J Diekema  1 , Michelle F Kuxhausen  7 , Amy Blevins  8 , Melissa A Ward  1 , Jennifer S McDanel  1 , Rajeshwari Nair  1   3 , Erin Balkenende  1 , Marin L Schweizer  1   3
Affiliations
Meta-Analysis

Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis

Alexandre R Marra et al. JAMA Netw Open. .

Abstract

Importance: An understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions.

Objective: To quantify the incidence of CDI and its associated hospital length of stay (LOS) in the United States using a systematic literature review and meta-analysis.

Data sources: MEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science were searched for studies published in the United States between 2000 and 2019 that evaluated CDI and its associated LOS.

Study selection: Incidence data were collected only from multicenter studies that had at least 5 sites. The LOS studies were included only if they assessed postinfection LOS or used methods accounting for time to infection using a multistate model or compared propensity score-matched patients with CDI with control patients without CDI. Long-term-care facility studies were excluded. Of the 119 full-text articles, 86 studies (72.3%) met the selection criteria.

Data extraction and synthesis: Two independent reviewers performed the data abstraction and quality assessment. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of hospital-onset CDI incident cases and the denominators across studies. Random-effects models were used to obtain pooled mean differences. Heterogeneity was assessed using the I2 value. Data analysis was performed in February 2019.

Main outcomes and measures: Incidence of CDI and CDI-associated hospital LOS in the United States.

Results: When the 13 studies that evaluated incidence data in patient-days due to hospital-onset CDI were pooled, the CDI incidence rate was 8.3 cases per 10 000 patient-days. Among propensity score-matched studies (16 of 20 studies), the CDI-associated mean difference in LOS (in days) between patients with and without CDI varied from 3.0 days (95% CI, 1.44-4.63 days) to 21.6 days (95% CI, 19.29-23.90 days).

Conclusions and relevance: Pooled estimates from currently available literature suggest that CDI is associated with a large burden on the health care system. However, these estimates should be interpreted with caution because higher-quality studies should be completed to guide future evaluations of CDI prevention and treatment interventions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Samore reported receiving an Epicenter grant from the Centers for Disease Control and Prevention (CDC) and grants from the Department of Veterans Affairs (VA), Agency for Healthcare Research and Quality, National Institutes of Health, Western Institute for Biomedical Research, and Pfizer outside the submitted work. Ms Ward and Dr Nair reported receiving Epicenter grants from the CDC during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Literature Search for Articles That Evaluated Incidence and Length of Stay (LOS) Associated With Clostridium difficile Infection
CINAHL indicates Cumulative Index of Nursing and Allied Health.
See this image and copyright information in PMC

Comment in

References

    1. Magill SS, O’Leary E, Janelle SJ, et al. ; Emerging Infections Program Hospital Prevalence Survey Team . Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):-. doi:10.1056/NEJMoa1801550 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published April 23, 2013. Accessed November 7, 2019.
    1. Gerding DN, Meyer T, Lee C, et al. . Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015;313(17):1719-1727. doi:10.1001/jama.2015.3725 - DOI - PubMed
    1. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398-408. doi:10.1001/jama.2014.17103 - DOI - PMC - PubMed
    1. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States: a meta-analysis and modelling study. BMC Infect Dis. 2016;16(1):447. doi:10.1186/s12879-016-1786-6 - DOI - PMC - PubMed

Publication types

MeSH terms